+152.4%
MRNA vs OVV
+46.6%
+105.8%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | OVV | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.3% | -0.3% | +1.5% | +1.3% |
| 7D | -13.8% | -5.1% | -8.8% | -13.2% |
| 30D | -17.7% | -12.4% | -5.3% | -16.2% |
| 3M | +14.3% | -5.6% | +19.9% | +14.5% |
| 6M | +336.0% | +2.1% | +333.8% | +329.5% |
| YTD | +575.9% | +59.6% | +516.3% | +482.2% |
| 1Y | +724.4% | +60.9% | +663.4% | +607.0% |
| All | +152.4% | +46.6% | +105.8% | +104.6% |
Cumulative growth
Daily Returns
Daily percentage return beside OVV.
Daily Out/Under-Performance
Portfolio return minus OVV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × OVV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded OVV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling